Covidien Receives FDA Clearance To Market Single-Incision Laparoscopic Surgery (SILS(TM)) Kit
Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS? Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.
More: continued here
Filed under: GastroIntestinal / Gastroentorology on May 22nd, 2008